Thyroid hormone and atherosclerosis (Q37609631)

21 August 2017

1 reference

title

Thyroid hormone and atherosclerosis (English)

1 reference

21 August 2017

1 reference

Toshihiro Ichiki

1

1 reference

21 August 2017

4 October 2009

1 reference

21 August 2017

Vascular Pharmacology

1 reference

21 August 2017

52

1 reference

21 August 2017

3-4

1 reference

21 August 2017

151-156

1 reference

Homocysteine, folate, vitamin B12, and transcobalamins in patients undergoing successive hypo- and hyperthyroid states

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Reversible hypertension and hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Hypothyroidism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid status, cardiovascular risk, and mortality in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Retinoic acid and triiodothyronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Serum and red cell folate and serum vitamin B12 levels in hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Endothelial dysfunction as an early sign of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

A correlation of clinical and hemodynamic studies in patients with hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Homocysteine: role and implications in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Rapid nongenomic actions of thyroid hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Reactive oxygen species-mediated homologous downregulation of angiotensin II type 1 receptor mRNA by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Hormonal regulation of rat adrenomedullin gene in vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Regulation of iodothyronine deiodinase and roles of thyroid hormones in human coronary artery smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid hormone and the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Elevated serum lipoprotein(a) in subclinical hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid hormone receptor-beta is associated with coronary angiogenesis during pathological cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Renin-angiotensin system in thyroid dysfunction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Subclinical hypothyroidism is associated with coronary artery disease in older persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Decrease in carotid intima‐media thickness in hypothyroid patients after normalization of thyroid function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Increased pulse wave velocity in subclinical hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Folate-mediated incorporation of ring-2-carbon of histidine into nucleic acids: influence of thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Impact of hyperthyroidism and its correction on vascular reactivity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Intima-media thickness: a tool for atherosclerosis imaging and event prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Increased central arterial stiffness in hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Acute effects of thyroid hormone on vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Treating hypothyroidism improves endothelial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

PLasma renin activity in syndromes of thyroid hormone excess and deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Inflammatory angiogenesis in atherogenesis--a double-edged sword

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Hypertension in thyroid disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Renin and aldosterone in hypothyroidism: relation to excretion of sodium and potassium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Homocysteine concentrations in subclinical hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Cardiac angiotensin receptors in experimental hyperthyroidism in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Alterations in Thyroid Status Modulate Apolipoprotein, Hepatic Triglyceride Lipase, and Low Density Lipoprotein Receptor in Rats*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Myxedema and Coronary Artery Disease—A Comparative Autopsy Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Risk factors for cardiovascular disease in patients with subclinical hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Homocysteine and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

Matrix GLA protein and BMP‐2 regulate osteoinduction in calcifying vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.004

10.1016/J.VPH.2009.09.004

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19808101